Nano Labs Ltd
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $3.8M | $5.6M | $11.1M | $141.2M |
| Cost of Revenue | $9.5M | $4.0M | $25.7M | $108.1M |
| Gross Profit | $-5.7M | $1.6M | $-14.6M | $33.0M |
| Gross Margin | -147.3% | 28.6% | -132.1% | 23.4% |
| Operating Expenses | ||||
| Research & Development | $1.1M | $7.0M | $12.5M | $18.9M |
| SG&A Expense | $7.8M | $7.1M | $7.5M | $7.6M |
| Operating Income | $10.2M | $-13.7M | $-36.8M | $3.0M |
| Operating Margin | 264.4% | -242.7% | -332.9% | 2.1% |
| Interest Expense | — | — | — | — |
| Pretax Income | $17.9M | $-16.6M | $-35.9M | $4.5M |
| Income Tax Expense | — | — | $-2.5K | $0 |
| Net Income | $19.3M | $-15.7M | $-35.7M | $4.5M |
| Net Margin | 501.6% | -278.8% | -322.7% | 3.2% |
| EPS (Basic) | $0.97 | $-0.98 | $-0.31 | $0.02 |
| EPS (Diluted) | $0.97 | $-0.98 | $-0.31 | $0.02 |
| Shares Outstanding (Basic) | 19.9M | 16.1M | 11.8M | 10.6M |
| Shares Outstanding (Diluted) | 19.9M | 16.1M | 11.8M | 10.7M |
| Dividends Per Share | — | — | — | — |